Detalhe da pesquisa
1.
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study.
Cancer Immunol Immunother
; 72(6): 1405-1415, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445410
2.
Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.
Clin Chem
; 66(1): 169-177, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31672856
3.
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.
Lancet Oncol
; 16(8): 908-18, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115796
4.
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
N Engl J Med
; 364(26): 2507-16, 2011 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21639808
5.
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
Lancet
; 379(9829): 1893-901, 2012 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22608338
6.
Improved survival with ipilimumab in patients with metastatic melanoma.
N Engl J Med
; 363(8): 711-23, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525992
7.
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669791
8.
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma.
Invest New Drugs
; 30(3): 1074-81, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21331745
9.
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
Invest New Drugs
; 29(3): 489-98, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20082117
10.
Systemic treatment of metastatic melanoma: new approaches.
J Surg Oncol
; 104(4): 425-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21858838
11.
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study.
Lancet Oncol
; 11(2): 155-64, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20004617
12.
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19.
Sci Transl Med
; 13(620): eabj7790, 2021 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648357
13.
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.
Cancer Immun
; 10: 9, 2010 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20957980
14.
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
J Immunother Cancer
; 8(1)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385146
15.
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical Trials.
JAMA Oncol
; 6(8): 1256-1264, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32672795
16.
mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.
Clin Chem
; 55(4): 757-64, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19233913
17.
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.
BMC Cancer
; 9: 263, 2009 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19643020
18.
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy.
Clin Cancer Res
; 13(7): 2068-74, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17404088
19.
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.
Cancer Res
; 66(12): 6111-7, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16778184
20.
Estrogen receptor-alpha methylation predicts melanoma progression.
Cancer Res
; 66(13): 6692-8, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16818643